Wasatch Micro Cap Fund’s Q1 Top Detractor: Frequency Therapeutics Inc. (FREQ) Wasatch Global Investors, an investment management firm, published its “Wasatch Micro Cap Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.95% was recorded by the fund for the Q1 of 2021, trailing the benchmark, Russell Microcap Index, which rose 23.89% for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021. Wasatch Micro Cap, in its Q1 2021 investor letter, mentioned Frequency Therapeutics, Inc. (NASDAQ: FREQ), and shared their insights on the company. Frequency Therapeutics, Inc. is a Woburn, Massachusetts-based biotechnology company that currently has a $355.8 million market capitalization. Since the beginning of the year, FREQ delivered a -70.50% return, while its 12-month gains are down by -43.04%. As of May 07, 2021, the stock closed at $10.40 per share.